Application no. and date | 17194591.8 (espacenet) (Federated) (European Patent Register), 20140205 | Patent/reg. no. and date | DK/EP 3311824, 20200325 | Publication date | 20180425 | Priority no. and date | US 201361761133 P, 20130205 | EP pub. no. and date |
EP 3311824 20180425 | Effective date | | Applicant/owner | The Regents of the University of California, 1111 Franklin Street, 12th Floor
Oakland, CA 94607-5200, US, The United States of America, as represented by The Secretary, Department of Health and Human Services, 6011 Executive Boulevard Suite 325, MSC 7660
Bethesda, Maryland 20892-7660, US, The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386
Stanford, CA 94305-2038, US | Applicant ref. no. | P72666DK01 | Inventor | WEISKOPF, Kipp, 28 Stanton Road, Unit 5
Brookline Massachusetts 02445, US, HASENKRUG, Kim J., 1990 Red Crow Road
Victor, MT Montana 59875, US, STODDART, Cheryl A., 360 Esplanade Avenue Apt. 10
Pacifica, CA California 94044, US, MCCUNE, Joseph M., 904 Steiner Street
San Francisco, CA California 94117, US, WEISSMAN, Irving L., 747 Santa Ynez Street
Stanford, CA California 94305, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 35/00 (2006.01) , A61P 31/12 (2006.01) | Title | CD47 MÅLRETTEDE TERAPIER TIL BEHANDLINGEN AF INFEKTIONSSYGDOMME | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|